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Different immune activation states require distinctmetabolic
features and activities in immune cells. For instance, inhibition
of fatty acid synthase (FASN), which catalyzes the synthesis of
long-chain fatty acids, prevents the proinflammatory response
inmacrophages; however, the precise role of this enzyme in this
response remains poorly defined. Consistent with previous
studies,we foundhere that FASN is essential for lipopolysaccha-
ride-induced, Toll-like receptor (TLR)-mediated macrophage
activation. Interestingly, only agents that block FASN upstream
of acetoacetyl-CoA synthesis, including the well-characterized
FASN inhibitor C75, inhibited TLR4 signaling, while those act-
ing downstream had no effect. We found that acetoacetyl-CoA
could overcome C75’s inhibitory effect, whereas other FASN
metabolites, including palmitate, did not preventC75-mediated
inhibition. This suggested an unexpected role for acetoacetyl-
CoA in inflammation that is independent of its role in palmitate
synthesis. Our evidence further suggested that acetoacetyl-CoA
arising from FASN activity promotes cholesterol production,
indicating a surprising link between fatty acid synthesis and
cholesterol synthesis. We further demonstrate that this process
is required for TLR4 to enter lipid rafts and facilitate TLR4 sig-
naling. In conclusion, we have uncovered an unexpected link
between FASN and cholesterol synthesis that appears to be
required for TLR signal transduction and proinflammatory
macrophage activation.
In immune cells, different activation states require distinct
types of metabolism for the cell to carry out their biological
function. For example, in response to the Gram-negative bac-
terial product, LPS, macrophages switch their core metabolism
fromoxidative phosphorylation to glycolysis to control the pro-
duction of ATP (1). This is a prerequisite to promote inflam-
mation and fight infection as inhibitors of glycolysis reduce
macrophage activation (2, 3). Conversely, macrophages that
play a key role in wound healing and tissue repair meet their
energetic requirements predominantly using oxidative phos-
phorylation (4).
Whereas alterations in glucose metabolism have been well-
characterized, it is now evident that lipid metabolism is also
altered depending on the activation state of a cell (5). The con-
sumption of fatty acids through !-oxidation in the mitochon-
dria is the predominant fuel used by M2 or alternatively acti-
vated macrophages, and this promotes an anti-inflammatory
phenotype (6, 7). On the other hand, synthesis of lipids
is associated with a pro-inflammatory phenotype (2, 8).
Whereas inhibition of glycolysis prevents a pro-inflamma-
tory response, there have only been limited studies on
whether lipid metabolism is also essential for the pro-in-
flammatory response or whether it may have the potential to
be targeted therapeutically.
Fatty acid synthase (FASN)2 is a homodimeric enzyme that
contains multiple catalytic domains that operate in a cyclical
loop to produce palmitate. The precursor metabolites used for
palmitate synthesis are acetyl-CoA and malonyl-CoA with the
carbon backbone being extended by 2 carbons with each cycle
through a series of six intermediate reactions. First, acetyl-CoA
and malonyl-CoA are conjugated to the acyl-carrier protein
(ACP) by the malonyl/acetyltransferase reversible enzymatic
domain, and this allows the retention of the metabolite to
FASN. Acetyl-ACP and malonyl-ACP then undergo a conden-
sation reaction to produce acetoacetyl-ACP in the 3-ketoacyl
synthase domain.Acetoacetyl-ACP is reduced to!-hydroxybu-
tyryl-ACP in the 3-ketoacyl reductase domain, dehydrated to
crotonyl-ACP by the 3-hydroxyacyl dehydrase domain, and
finally reduced to butyryl-ACP by the enoyl reductase domain.
As this cycle repeats, a new malonyl-CoA molecule is used to
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palmitate is produced and is cleaved by the thioesterase domain
(9, 10).
FASN is predominantly regulated by the sterol regula-
tory element–binding proteins (SREBPs), of which there
are three isoforms: SREBP1a, SREBP1c, and SREBP2 (11).
Whereas SREBP1 has been more associated with transcrip-
tion of fatty acid synthesis genes and SREBP2 more associ-
ated with cholesterol-related genes, they are both activated
by the same signal, a reduction in cholesterol. This indicates
an uncharacterized link between fatty acid synthesis and
cholesterol synthesis.
The synthesis of cholesterol in cells is a complex pathway
that uses acetyl-CoA to produce the 27-carbon structure of
cholesterol (12). Cholesterol provides structure and fluidity to
the membranes of the cell and allows mammalian cells to dis-
pense with a cell wall. Similar to fatty acid synthesis, low levels
of cellular cholesterol activate the SREBPs to induce a range of
genes associated with cholesterol production and cholesterol
uptake. Conversely, when cholesterol levels are high, they acti-
vate the liver X receptor transcription factors that promote the
transcription of cholesterol exporters to balance cholesterol
levels via cholesterol efflux (13, 14). It is important for the cell to
be capable of tightly regulating cholesterol levels. For instance,
high levels of cholesterol in macrophages lead to foam cell dif-
ferentiation, and these cholesterol-rich macrophages are asso-
ciated with a poor prognosis in atherosclerosis (15, 16), dem-
onstrating that cholesterol metabolism is a key biosynthetic
pathway in macrophages.
Here we provide evidence for a biosynthetic link between
fatty acid synthase and cholesterol synthesis. Our data sug-
gest that the production of acetoacetyl-CoA by FASN
through its ketoacyl synthase domain during LPS stimula-
tion is important for a pro-inflammatory response. The
mechanism involves a link to cholesterol synthesis from
FASN-derived acetoacetyl-CoA that is required for choles-
terol synthesis and subsequent lipid raft formation, which is
essential for TLR signaling. We conclude that the synthesis
of cholesterol during LPS stimulation is closely tied to FASN,
identifying a previously unknown link between these two
biosynthetic link pathways.
Results
FASN is essential for inflammatory signaling in response to
LPS
To investigate the role of FASN inmacrophage activation,we
first used a genetic approach to knock down the FASN protein
using two independent siRNAs. We found that following
reduction of FASN protein in macrophages, they produced less
IL1!, TNF-", and IL6 in response to LPS stimulation (Fig. 1A).
To further establish a role for FASN in the LPS activation of
macrophages by LPS, we used the well-characterized FASN
inhibitor, C75. As can be seen in Fig. 1B, C75 effectively inhib-
ited the production of the pro-inflammatory cytokines IL1!
and TNF-" and the anti-inflammatory cytokine IL10 at all time
points tested following LPS stimulation. Furthermore, we
found that FASN inhibition led to a decrease in TNF-", IL6,
IL10 (Fig. 1C), and IL1! (Fig. 1D, lanes 6 and 7 compared with
lane 5 ) in a dose-dependent manner upon LPS stimulation. A
second characterized inhibitor of FASN, cerulenin, also had a
similar effect, as it decreased IL1! induction in response to LPS
in a dose-dependent manner (Fig. 1E, lanes 6 and 7 compared
with lane 5 ). Neither inhibitor exerted any cytotoxic effects in
bone marrow–derived macrophages (BMDMs) (Fig. S1A).
Finally, we also investigated whether FASN inhibition in vivo
had similar effects and found that C75 significantly reduced
serum IL1! levels in response to LPS (Fig. 1F). These results
indicate that FASN activity, in vitro and in vivo, is required for
macrophage activation and IL1! production in response to
LPS.
FASN is essential for a variety of inflammatorymediators
We next expanded our study to investigate whether FASN
was a key regulator for other activators of macrophages. As
demonstrated in Fig. 2A, FASN inhibition dramatically reduced
the levels of Il1b,Tnfa, Il6, and Il10 in response to a broad range
of TLR agonists (LPS, Pam3Csk4, R848, and CpG DNA). C75
induced the expression of two genes that have been reported
to increase with C75 treatment: the adipose-related gene,
Adrp, and the antioxidant gene, Nqo1, demonstrating that
inhibition of FASN did not merely lead to an overall inhibi-
tion of cellular transcription (17, 18). The TLR ligands had
no effect on the gene responses ofAdrp orNqo1. As shown in
Fig. 2B, FASN inhibition also reduced the levels of IL1!,
TNF-", IL6, and IL10 in response to both heat-killed
Staphlyococcus aureus and Salmonella typhurium. C75 also
inhibited induction of Tnfa mRNA in response to a range of
doses of TNF-" itself (Fig. 2C). The effect of FASN inhibition
in TNF-" activated BMDMs also occurred in a dose-depen-
dent manner (Fig. 2D). This meant that the biological effect
of C75 was common to both TLR and TNF-" signaling path-
ways. Altogether, these results show that FASN plays a broad
regulatory role in response to a wide variety of inflammatory
stimuli in macrophages.
The ketoacyl synthase domain of FASN is essential for
macrophage activation
FASN is a multidomain enzyme that, through a series of
cyclical reactions, extends a carbon backbone for the pro-
duction of palmitate (10). To investigate whether the six
different enzymatic domains of FASN had varying roles in
the response to LPS, we treated BMDMs with a range of
known FASN inhibitors that targeted different domains (Fig.
3A). Fig. 3B illustrates the effect of the FASN inhibitors IL1!,
TNF-", and IL10 production. We found that inhibition at or
before the ketoacyl synthase domain (with quercetin, ceru-
lenin, or C75) prevented the induction of TNF-" or IL1!
LPS stimulation (Fig. 3, B and C, lanes 8–10 ). However,
inhibitors that targeted enzymatic domains downstream of
the ketoacyl synthase domain (GSK2194069 and orlistat)
had no effect on LPS-mediated effects in either mouse
BMDMs or human monocyte–derived macrophages (Fig. 3
(B and C), lanes 11 and 12 ). We concluded that enzymatic
domains of FASN that were at or above the ketoacyl synthase
domain were critical for LPS activation of macrophages,
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whereas other domains within the FASN holoenzyme were
dispensable.
Acetoacetyl-CoA is a keymetabolite involved in C75 inhibition
ofmacrophage activation
Following the observation that different enzymatic domains
of FASN had varying effects on LPS signaling, we hypothesized
that intermediate metabolites produced by different FASN
domains could be contributing to the cellular responses of LPS,
perhaps even independently of their role in palmitate synthesis.
To further investigate the role of FASN intermediate metabo-
lites, we supplemented the medium with each of the interme-
diatemetabolites (acetyl-CoA,malonyl-CoA, acetoacetyl-CoA,
butyryl-CoA, hydroxybutyryl-CoA, and palmitate) in BMDMs
activated with LPS and C75. This is a common approach used
to study inhibitors of FASN, as the metabolites are stable in
solution for up to 24 h (9, 19, 20). Interestingly, only one inter-
mediate metabolite prevented the inhibition of IL1! during
FASN inhibition, acetoacetyl-CoA. This can be seen in Fig. 4A,
where, in the case of acetyl-CoA, malonyl-CoA, butyryl-
CoA, hydroxybutyryl-CoA, or palmitate, nomodulation of C75
effects was seen (compare lane 8 with lane 4 in each case),
Figure 1. Fatty acid synthase is required for a pro-inflammatory response to LPS. A, BMDMswere transfectedwith either a scramble siRNA control or two
independent FASNsiRNAs (10nM) for 96h. Cellswere then treatedwith LPS (10ng/ml) for 4h. IL1!wasmeasuredbyWesternblotting. TNF-", IL6, and IL10were
measured by ELISA. B, BMDMs were pretreated with DMSO or C75 (50 #M) for 1 h. Cells were then treated with LPS (10 ng/ml) for the indicated times. C–E,
BMDMswere pretreatedwith the indicated dose of C75 (C andD) or cerulenin (E) for 1 h. Cells were then treatedwith LPS (10 ng/ml) for 4 h. F, C57Blmicewere
injected intraperitoneally with vehicle or C75 (10mg/kg) for 30min. Mice were subsequently injected intraperitoneally with LPS (10mg/kg) for 90min. Serum
was isolated from whole blood, and levels of IL1!, TNF-", and IL10 were measured by ELISA. Western blots are representative of three independent experi-
ments. A, B, and E, graphs represent the mean! S.E. (error bars) (n" 3). A and F, data represent mean! S.E. (n" 12/group); *, p# 0.05; **, p# 0.01; ***, p#
0.001, one-way ANOVA.
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whereas acetoacetyl-CoA blocked the inhibitory effect of C75
(bottom left panel; compare lane 8with lane 4 ). This result was
interesting, as acetoacetyl-CoA is produced by the ketoacyl
synthase domain, the same domain that the inhibitor panel
screen indicated was critical for macrophage activation. We
next confirmed that acetoacetyl-CoA could be taken up by
macrophages. Although metabolomic analysis did not detect
acetoacetyl-CoA itself, most likely due to the extraction pro-
tocol used, it showed a significant increase in coenzyme A
metabolism suggestive of uptake of acetoacetyl-CoA (Fig.
S2, A and B). We next tested whether the reduction of
IL1! in response to LPS following FASN knockdown could
be prevented by acetoacetyl-CoA. We found that aceto-
acetyl-CoA could prevent IL1! reduction following FASN
knockdown, further supporting our hypothesis (Fig. 4B,
compare lanes 8 and 9 with lanes 5 and 6). These data indi-
cate that there is a surprising link between the metabolite
acetoacetyl-CoA produced in fatty acid synthesis and LPS
action in macrophages.
LPS signaling is abrogated following FASN inhibition
We next wanted to establish at which point of the TLR4
pathway acetoacetyl-CoAmight be exerting its effects. First we
wished to findwhether the inhibition of LPS-mediated cytokine
production occurred at the pre- or post-transcriptional level.
To this end, we analyzed mRNA levels of pro-inflammatory
cytokines in BMDMs that had been treated with LPS and C75.
We found that FASN inhibition decreased Il1!, Tnfa, Il6, and
Il10 at the transcriptional level (Fig. 5A). We found that FASN
inhibition also led to a dramatic reduction in p65 translocation
Figure 2. Fatty acid synthase is essential for response to various inflammatory stimuli.A, BMDMswere pretreatedwithDMSOor C75 (50#M) for 1 h. Cells
were then treated with LPS (10 ng/ml), Pam(3)Csk(4) (1#g/ml), R848 (1#g/ml), or CpG DNA (1#g/ml) for 4 h. mRNAwas extracted fromwhole-cell lysate and
analyzed by qPCR for the indicated genes. B, BMDMs were pretreated with DMSO or C75 (50 #M) for 1 h. Subsequently, cells were treated with heat-killed
S. aureus (108 cells/ml) or heat-killed S. typhimurium (109 cells/ml) for 4 h. IL1!wasmeasuredbyWesternblotting. TNF-", IL6, and IL10weremeasuredby ELISA.
C andD, BMDMswere pretreatedwith DMSO or the indicated dose of C75 for 1 h. BMDMswere subsequently treatedwith the indicated dose of TNF-" for 4 h.
mRNA was extracted, and levels of Tnfawere analyzed by qPCR. A–C, graphs represent the mean! S.E. (error bars) (n" 3). **, p# 0.01; ***, p# 0.001; ns, not
significant, one-way ANOVA.
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to the nucleus following LPS stimulation (Fig. 5B, compare lane
8with lane 7 ), demonstrating that the inhibition was occurring
upstream of p65 nuclear translocation. As shown in Fig. 5C,
FASN inhibition also prevented the degradation of I$B and dra-
matically reduced the phosphorylation of p65, IKK"/!, and
TAK1 while also blocking the production of IL1! (compare
lanes 6–10 with lanes 1–5 ). This result suggested that the inhi-
bition of the TLR4 pathway by C75 was upstream in the path-
way and proximal to the receptor. Furthermore, C75 had no
effect on TLR4 activation that was independent of LPS. As can
be seen in Fig. 5D, C75 had no effect on NF$B activation when
the TLR4 pathway was activated by overexpressing IRAK1, fur-
ther suggesting that C75 was not nonspecifically blocking com-
ponents of the TLR4 pathway.
Figure 3. The ketoacyl synthase domain of FASN is essential for macrophage activation. A, schematic representation of reactions carried out by the
holoenzyme of FASN to produce palmitate. FASN domains and inhibitors used to target them are in boldface type. B and C, BMDMs or human monocyte–
derivedmacrophages were pretreated with C75 (50#M), cerulenin (50#M), GSK2194069 (1#M), or orlistat (100#M inmice and 50#M in humans) for 1 h. Cells
were subsequently treatedwith LPS (10 ng/ml) for 4 h. IL1!wasmeasured byWestern blotting. TNF-" and IL10weremeasured by ELISA. Graphs represent the
mean! S.E. (error bars) (n" 4). ***, p# 0.001, one-way ANOVA.
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FASN producesmetabolites to promote the synthesis of
cholesterol
As palmitate did not rescue the effects of FASN inhibition,
this suggested that acetoacetyl-CoA produced by FASN must
also have an alternative role that is independent of its role in
producing palmitate through FASN. Acetoacetyl-CoA is not
only a metabolic intermediate for fatty acid synthesis but also
an essential metabolite in cholesterol synthesis. Cholesterol is
also a key component of the signaling platforms known as lipid
rafts, which are essential for TLR4 signaling (21–23). We
hypothesized that FASN may be regulating cholesterol levels,
which in turn would alter the lipid raft structure during TLR
signaling. This would explain why all tested phosphorylation
events of the TLR4 pathway were down-regulated. To investi-
gate whether this link between FASN and cholesterol synthesis
existed, we treated BMDMs with the panel of FASN inhibitors
andmeasured cholesterol levels. As shown in Fig. 6A, we found
that inhibition of FASN did reduce cholesterol levels to a sig-
nificant degree in BMDMs, but, once again, only inhibitors that
inhibited at or above the ketoacyl synthase domain led to a
significant reduction in cholesterol levels. This demonstrated
that inhibition of FASN also reduced cellular cholesterol levels,
providing more evidence that the two pathways are linked. To
further investigate the link between FASN and cholesterol syn-
thesis, we next supplemented serum-free medium with aceto-
acetyl-CoA or a metabolite of cholesterol synthesis, HMG-
CoA, followed by FASN inhibition with C75. We found that
these metabolites could recover cholesterol levels following
FASN inhibition (Fig. 6B). A biological hallmark of reduced
cellular cholesterol levels is an increase in the cleavage of
SREBPs. Fig. 6C shows that whereas LPS has little effect on
SREBP1 cleavage over a 6-h time course, FASN inhibition does
lead to an increase of SREBP1 cleavage (Fig. 6C, compare lanes
6–10 with lanes 1–5 , respectively). Because SREBP1 is being
controlled by SCAP, which is sensitive to cholesterol levels (24,
25), this provides yet another link between FASN and choles-
terol synthesis. Exogenous cholesterol was not able to rescue
the inhibitory phenotype of C75 (Fig. 6D), although it has been
shown recently that cholesterol uptake and cholesterol synthe-
sis have differing effects on cholesterol locations and subse-
Figure 4. Acetoacetyl-CoA is a keymetabolite involved in C75 inhibition ofmacrophage activation. A, BMDMswere cultured inmedium containing the
intermediate metabolites of fatty acid synthase: acetyl-CoA (1 mM), malonyl-CoA (1 mM), butyryl-CoA (1 mM), hydroxybutyryl-CoA (1 mM), acetoacetyl-CoA (1
mM), or palmitate-BSA (10mM) for 3 h before treatment. Cells were then treatedwithDMSOor C75 (50#M) for 1 h, followedby LPS (10 ng/ml) treatment for 4 h.
IL1!was measured by Western blotting. B, macrophages were treated with either control siRNA or two independent siRNAs (10 nM) targeting FASN for 96 h.
Cells were then pretreated with acetoacetyl-CoA (1 mM) for 3 h, followed by treatment with LPS (10 ng/ml) for 4 h. IL1! and FASN levels were measured by
Western blotting.
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quent cellular effects (26). This suggests that cholesterol syn-
thesis and cholesterol uptake are two independent events that
do not always compensate for each other (26). To investigate
whether cholesterol synthesis could rescue the inhibitory phe-
notype of FASN inhibition, we supplemented themediumwith
the cholesterol metabolite, HMG-CoA, and treated BMDMs
with LPS in the presence or absence of C75. We found that
HMG-CoA could also rescue IL1! production in response to
LPS following FASN inhibition (Fig. 6E, compare lanes 5 and 6
with lane 4 ). This is a key finding, as it shows that a cholesterol
metabolite can rescue the effects of FASN inhibition and indi-
cates a novel biosynthetic link between FASN and cholesterol
Figure 5. Fatty acid synthase inhibition blocks all associated LPS signaling. A, BMDMs were treated with DMSO or C75 (50 #M) for 1 h. Cells were then
treatedwith LPS (10 ng/ml) for 4 h.mRNAwas extracted fromwhole-cell lysate, and the indicated geneswere analyzed by qPCR. Graphs represent themean!
S.E. (error bars) (n" 3). B, BMDMswere treatedwithDMSOor C75 (50#M) for 1 h. Cells were then treatedwith LPS for 30min. Nuclear and cytoplasmic fractions
were prepared from the cell lysate, and the location of p65 was analyzed byWestern blotting. C, BMDMs were treated with DMSO or C75 (50#M) for 1 h. Cells
were then treated with LPS (10 ng/ml) over a 90-min time course at the times indicated. Phosphorylation of p65, IKK"/!, and TAK1 of the TLR4 pathway was
analyzed by Western blotting. D, 293T cells were transfected with an NF$B luciferase construct (250 ng) and TK Renilla construct (150 ng) along with empty
vector or IRAK1 cDNA (1#g). Cellswere treatedwithC75 (50#M for 4h). NF$Bactivatedwasmeasuredusing luciferin,whereas TKRenilla acted as a controlwith
coelantrazine. n.s., not significant, one-way ANOVA.
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synthesis. Interestingly, it has been reported recently that mice
specifically lacking FASN in their myeloid cells displayed
reduced cellular cholesterol (27). This study suggested that
reduction in cholesterol levels upon FASN deletion was due to
an increase in LXR-dependent genes increasing cholesterol
efflux. We tested this in our system; however, we observed no
rescue of IL1! using the LXR antagonist, GSK2033, following
treatment with LPS and C75 (Fig. 6F, compare lane 8with lane
7 and lane 12 with lane 11). Furthermore, we observed no
increase in LXR-dependent genes in C75-treated samples rela-
tive to the LXR agonist, T0901317 (Fig. 6G; Lxra, Abca, and
Abcg). This indicated to us that in our system, the effects seen
here are due to a direct biosynthetic link between FASN and
cholesterol synthesis rather than the activation of LXRs; how-
ever, both observations are likely to contribute to overall cho-
lesterol metabolism in macrophage biology (27). These results
place FASN as an important enzyme and regulator of both
cholesterol synthesis and TLR signaling during macrophage
activation.
Fatty acid synthase regulation of cholesterol levels is vital to
maintenance of lipid rafts and associated inflammatory
signaling
Having established the link from FASN to cholesterol syn-
thesis, we next examined lipid rafts, as they contain high levels
of cholesterol and are important for TLR and TNF-" signaling
(23, 28, 29).We investigatedwhether inhibition of FASNwould
have any effects onTLR4 signaling through lipid rafts. As can be
seen in Fig. 6 (H–O), inhibition of FASN drastically reduces the
energy transferred between TLR4 and GM1. Following photo-
bleaching of TLR4 (Fig. 6, J and N compared with H and L) we
see an increase in fluorescent intensity of GM1 in the LPS-
treated macrophages (Fig. 6, K compared with I). This increase
is due to the loss of quenching by the GM1 stain as the TLR4
molecule moved into the lipid raft following LPS stimulation.
There is no significant increase in fluorescent intensity of the
GM1 stain when the macrophages are treated with C75, sug-
gesting that TLR4 has failed to translocate to the lipid raft (Fig.
6,O comparedwithM), and as such there is no quenching of the
signal. This energy transfer in stimulated conditions is quanti-
fied in Fig. 6P. This shows that FASN is essential for maintain-
ing the structure of lipid rafts, most likely via cholesterol syn-
thesis, to facilitate signaling in response external stimuli. We
also investigated the role of lipid rafts using colocalization anal-
ysis and similarly found that FASN inhibition reduced the co-
localization of TLR4 with GM1 ganglioside when compared
with the increase in colocalization seen with LPS stimulation
(Fig. 6Q, R(obs) " 0.925 in LPS-treated compared with
R(obs) " 0.124 in LPS $ C75). We also used biochemical iso-
lation of lipid rafts to investigate whether TLR4 translocation
was altered by C75. As shown in supporting Fig. 3A, we found
that TLR4 was present in fractions 1–2 following LPS treat-
ment, indicating that it had translocated to the lipid raft com-
pared with its absence in fractions 1–2 when macrophages had
been pretreated with C75. These results demonstrated that
inhibition of FASN was preventing TLR4 translocation to the
lipid raft.
As CD14 is permanently sequestered in the lipid raft (13, 23),
it is likely that the failure of TLR4 translocation to the lipid raft
would reduce the signaling in response to LPS stimulation.
Taken together, these data identify a biosynthetic link from
FASN to cholesterol synthesis in the form of acetoacetyl-CoA
with cholesterol synthesis being required for TLR4 signaling.
Discussion
Here we provide evidence for an unexpected link between
the fatty acid synthesis pathway and the cholesterol synthesis
pathway with the FASN metabolite, acetoacetyl-CoA, provid-
ing the link. We show that FASN is required not only for LPS
activation of macrophages but also for macrophage activation
by multiple TLR agonists and TNF-". Our study implicates
acetoacetyl-CoA as a metabolite in inflammatory macrophage
activation. Our evidence suggests that interfering with ace-
toacetyl-ACP synthesis by FASN will decrease cholesterol levels
and disrupt the lipid raft, resulting in TLR4 failing to translo-
cate to the lipid raft and impairing TLR4 signaling. Whereas
there is probably an increase in the proportional amounts of
sphingolipids within the lipid raft, leading to brighter GM1
staining, this does not lead to an increase in the transfer of
energy to the photobleached TLR4, indicating that the sphin-
golipids are unlikely to be compensating functionally for cho-
lesterol in TLR4 signaling. It has also been shown that TLR4
contains a cholesterol-binding motif, known as a cholesterol
recognition amino acid consensus (CRAC), and this domain is
hypothesized to play an important role in translocatingTLR4 to
Figure 6. Fatty acid synthase inhibition decreases cholesterol levels. A, BMDMs were treated with DMSO, cerulenin (50 #M), C75 (50 #M), GSK2194069 (1
#M), and orlistat (50 #M) for 6 h in serum-free medium. Lipids were extracted, and cholesterol was measured using cholesterol oxidase and Amplex red. B,
BMDMs were treated cultured in serum-free medium alone or serum-free medium containing acetoacetyl-CoA (1 mM) or HMG-CoA (1 mM) for 1 h. Cells were
then treatedwithDMSOorC75 (50#M) for 6 h. Lipidswere extracted, and cholesterolwasmeasuredusing cholesterol oxidase andAmplex red.C, BMDMswere
treated with DMSO or C75 (50 #M) for 1 h. Cells were then treated with LPS (10 ng/ml) over a 6-h time course at the indicated times. SREBP1 cleavage and
activationweremeasuredbyWesternblotting.D, BMDMswere cultured inmediumsupplementedwith cholesterol (Gibco) for 3h. Cellswere then treatedwith
DMSO or C75 (50 #M) for 1 h, followed by LPS (10 ng/ml) treatment for 4 h. IL1! was measured by Western blotting. E, BMDMs were cultured in medium
containing the indicated dose of HMG-CoA for 3 h. Cells were then treatedwith DMSO or C75 (50#M) for 1 h before treatment with LPS (10 ng/ml) for 4 h. IL1!
wasmeasured byWestern blotting. F, BMDMs were pretreated with the indicated dose of GSK2033 for 1 h. Cells were then treated with DMSO or C75 (50#M)
for 1hbefore treatmentwith LPS (10ng/ml) for 4h. IL1!wasmeasuredbyWesternblotting.G, BMDMswere treatedwith the indicateddoseofC75or T0901713
(50#M) for 1 h. Cellswere then treatedwith LPS (10 ng/ml) for 4 h.mRNAwas extracted fromwhole-cell lysate, and the indicatedgeneswere analyzedbyqPCR.
H–O, BMDMswere treatedwithDMSOor C75 (50#M) for 1 h, followedby LPS (10 ng/ml) treatment for 30min. Energy transfer between TLR4 (I andM) andGM1
(H and L) canbedetected from the increase indonor fluorescence (K andO) after acceptor photobleaching (J andN). Thedonor (Alexa488) imageafter acceptor
photobleaching (K and O) demonstrates an increase in fluorescence when cells were stimulated with LPS. FRET was quantified from 10 images of each
treatmentwith4–5cells/image.n"3.P, energy transfer quantified in response toDMSO,C75, LPS, andLP$C75. Scale bar, 10#m.Q, BMDMswere treatedwith
DMSO or C75 (50 #M) for 1 h, followed by LPS (10 ng/ml) treatment for 30 min. Bar, 10 #m. The data are representative of three independent experiments.
Co-localization coefficients (R(obs)) were calculated usingCostes’ approach.A and B, data representmean! S.E. (error bars) (n" 3/group): **, p# 0.01; ***, p#
0.001; ns, not significant, one-way ANOVA.
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the lipid raft for efficient signaling, implying that cholesterol
may have a role beyond its role in lipid rafts in our study (30).
Inhibition of FASN resulted in SREBP1 cleavage that is a
hallmark of a reduction of cholesterol within the cell. A key
piece of evidence for the biosynthetic link between FASN and
cholesterol was that HMG-CoA, a metabolite unique to the
cholesterol pathway, was able to rescue IL1! production fol-
lowing the suppression caused by FASN inhibition.Overall, our
study indicates that along with the switch to glycolysis, an
increase in FASN leading to cholesterol production is also
required for macrophage activation.
The anti-inflammatory properties of FASN inhibition were
not associated with the whole enzyme and its ability to produce
palmitate, but rather the anti-inflammatory properties were
associated with the ketoacyl synthase domain. The ketoacyl
domain of FASN produces acetoacetyl-CoA using the precur-
sor metabolites malonyl-CoA and acetyl-CoA; however, in the
cholesterol pathway, acetoacetyl-CoA is synthesized when the
thiolase, ACAT, fuses two molecules of acetyl-CoA together.
This is interesting, as malonyl-CoA synthesis from acetyl-CoA
carboxylase is considered the key step that commits the car-
bons to fatty acid synthesis. It is also interesting to note that
condensation of malonyl-CoA and acetyl-CoA to produce ace-
toacetyl-CoA is considered a thermodynamically more favor-
able reaction than acetoacetyl-CoA formation using two acetyl-
CoA molecules, as malonyl-CoA contains more free energy
from the condensation reaction that forms malonyl-CoA (31).
This means that FASNmay be amore efficient pathway to alter
cellular cholesterol concentrations more rapidly than if the
cholesterol pathway alone was used. This is important during
inflammation, as cholesterol is a key component of the cell
membrane, and the cell membrane plays a key role during
macrophage activation. Macrophages not only have to have
optimal signaling from the cell membrane (e.g. TLR4), but they
may also have to alter their membrane drastically to allow for
phagocytosis while also ensuring that the membrane stays
intact to prevent cell death. This role of cholesterol during
macrophage activation may require FASN generated aceto-
acetyl-CoA to fulfill the cholesterol demands of the cell. Our
data are surprising because previous work on FASN implies
that there is no mechanism for the release of acetoacetyl-ACP
as acetoacetyl-CoA. One possible mechanism is that the malo-
nyl/acetyltransferase domain is a reversible domain, as shown
in fatty acid synthesis in bacteria (32).Whereas this domain has
been characterized to readily transfer short carbonmetabolites
to ACP, it is likely that it could work in reverse, similar to in
bacteria, to transfer short carbon metabolites back onto CoA.
In a study by Wei et al. (27), the role of FASN and macro-
phages in diet-induced obesity was investigated. They found
that a deficiency of FASN specifically in macrophages could
help protect against diet-induced insulin resistance and inflam-
mation. Interestingly, they found that macrophages lacking
FASN had reduced cholesterol levels that had led to an altera-
tion in the protein content of lipid rafts. This implicates FASN
as an important regulator of diet-induced diabetes. Our work
provides further support for the role of FASN as a central player
in inflammation inmore acute conditions, such as infections or
sepsis.Whereas chemotherapeutic agents have been developed
to target FASN, due to its importance in providing lipid for cell
growth in cancer, many of these agents target the ketoacyl-
reductase domain, as it is a chemically more favorable target to
inhibit. Had similar agents been designed against the ketoacyl-
synthase domain, it may have been possible to repurpose these
agents as anti-inflammatory agents. It has been also been
reported that cerulenin can reduce sterol levels in bacterial cul-
tures (33). The authors report that millimolar levels of ceru-
lenin are required to inhibit HMG-CoA synthase despite only
low micromolar levels being required for inhibition of sterol
synthesis. Our hypothesis helps to explain this concentration
discrepancy, as our data suggest a link between fatty acid syn-
thesis and cholesterol synthesis.
It has been reported that phosphorylation and nitrosylation
of fatty acid synthase can regulate its activity, so it is interesting
to speculate that, following LPS activation of macrophages,
FASNmodification can alter the intermediate metabolites pro-
duced to better adapt to the situation it requires (34, 35). It
would be interesting to see whether FASN or its modified form
also plays a role in the regulation of cholesterol levels in other
cell types that produce high levels of cholesterol, such as
hepatocytes.
In conclusion, we provide a biosynthetic link between fatty
acid synthesis and cholesterol synthesis that plays a key role in
activation of macrophages and production of IL1!. It has
recently been shown that IL1! is an important therapeutic tar-
get for risk of a second coronary event in at-risk patients (36).
There is a role for both cholesterol and IL1! in this process,
because cholesterol crystals activate NLRP3, leading to IL1!
production, and activated macrophages are present as foam
cells in atherosclerosis (37). Limiting the link between FASN
and cholesterol production may have therapeutic potential for
the treatment of inflammatory atherosclerosis, where macro-
phage foam cells play a key role.
Experimental procedures
Reagents
LPS used in in vitro studies was from Escherichia coli, sero-
type EH100 (Alexis). LPS for in vivo trials was from E. coli, sero-
type O55:B5 (Sigma-Aldrich). C75, cerulenin, quercetin, orl-
istat, GSK2194069, GSK2033, and T09031713 were purchased
from Sigma-Aldrich. FASN siRNA 1 (catalogue no. 4390815;
assay ID s65865), FASN siRNA 2 (catalogue no. 4390815; assay
ID s65867) and scrambled control (catalogueno. 4390843)were
purchased from Thermo Fisher Scientific. Heat-killed Salmo-
nella typhimurium and Staphylococcus aureus were purchased
from Invivogen. Antibodies used were anti-IL1! (R&D Sys-
tems, AF401-NA), anti-!-actin (Sigma-Aldrich, AC-74), anti-
SREBP1 (BD Pharmingen, 557063), anti-FASN (catalogue no.
3180), anti-p65 (catalogue no. 8242), anti-phospho-p65 (cata-
logue no. 3033), anti-phospho-TAK1 (catalogue no. 4508),
anti-phospho-IKK"/! (catalogue no. 2697), anti-tubulin (cata-
logue no. 5666), and anti-histone H3 (catalogue no. 4499) all
fromCell Signaling Technology. Secondary horseradish perox-
idase-conjugated anti-mouse IgG, anti-rabbit IgG, and anti-
goat IgG were from Jackson ImmunoResearch. Malonyl coen-
zyme A lithium salt, acetyl coenzyme A sodium salt, butyryl
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coenzyme A lithium salt, hydroxybutyryl coenzyme A lithium
salt, acetoacetyl coenzymeA sodium salt, and hydroxy-3-meth-
ylglutaryl coenzymeA sodiumsaltwere purchased fromSigma-
Aldrich. CytoTox 96 Non-radioactive Cytotoxicity Assay kit
was purchased from Promega. The caveolae/raft isolation kit
was purchased from Sigma-Aldrich (CS0750).
Mouse strains
C57Bl/6 mice were from Harlan U.K. Animals were main-
tained under specific pathogen-free conditions in line with
Irish and European Union regulations. Experiments were
approved by local ethical review (Health Products Regulatory
Authority) and in accordance with the Animals (Scientific Pro-
cedures) Act of 1986 and the GlaxoSmithKline policy on the
care, welfare, and treatment of animals.
Generation of BMDMs
Mice were euthanized in a carbon dioxide chamber, and
death was confirmed by cervical dislocation. Bonemarrow cells
were extracted from the leg bones and differentiated inDulbec-
co’s modified Eagle’s medium (containing 10% fetal calf serum,
1% penicillin/streptomycin, and 20% L929 supernatant) for 6
days, at which time they were counted and replated for
experiments.
Real-time PCR
RNA was isolated using the PureLink RNA minikit
(Ambion). cDNA was prepared using by RT-PCR using a high-
capacity cDNA reverse transcription kit (Applied Biosystems),
according to the manufacturer’s instructions. Real-time quan-
titative PCR (qPCR) was performed on cDNA (25 ng) on a 7500
Fast Real-Time PCR System (Applied Biosystems) using Pow-
erUpSYBRGreenMasterMix (AppliedBiosystems). The SYBR
primer pair sequences were as follows: Il1b, 5%-TGGCAACTG-
TTCCTG-3% (forward) and 5%-GGAAGCAGCCCTTCATC-
TTT-3% (reverse); Il10 , 5%-AGGCGCTGTCATCGATTT-3% (for-
ward) and 5%-CACCTTGGTCTTGGAGCTTAT-3% (reverse);
Tnfa, 5%-GCCTCTTCTCATTCCTGCTT-3% (forward) and 5%-
TGGGAACTTCTCATCCCTTTG-3% (reverse); Adrp, 5%-AAG-
AGGCCAAACAAAAGAGCCAGGAGACCA-3% (forward)
and 5%-ACCCTGAATTTTCTGGTTGGCACTGTGCAT-3%
(reverse); Nqo1, 5%-GCTGCAGACCTGGTGATATT-3% (for-
ward) and 5%-ACTCTCTCAAACCAGCCTTT-3% (reverse);
Rps18, 5%-GGATGTGAAGGATGGGAAGT-3% (forward) and
5%-CCCTCTATGGGCTCGAATTT-3% (reverse).
-Fold changes in expression were calculated using the &&Ct
method (38) using mouse Rps18 as the reference gene for nor-
malization. All -fold changes are expressed relative to the
untreated control.
Western blotting
Protein samples from cultured cells were prepared by direct
lysis of cells in 2' SDS sample buffer, followed by heating at
95 °C for 7 min. Protein samples were resolved on 8–12% SDS-
polyacrylamide gels and were then transferred to nitrocellulose
membrane. Membranes were blocked in 5% (w/v) dried milk in
Tris-buffered saline/Tween (TBST) for at least 1 h at room
temperature. Membranes were incubated with primary anti-
body, followed by the appropriate horseradish peroxidase–
conjugated secondary antibody. They were developed using
chemiluminescent (ECL) substrate (Millipore).
ELISA
Cytokine concentrations in cell supernatants weremeasured
using ELISA Duoset kits for mouse IL10 and TNF-" and IL6,
according to the manufacturer’s instructions. Cytokine con-
centrations in serum samples isolated from whole blood were
measured usingQuantikine ELISA kits formouse IL1!. Duoset
and Quantikine kits were from R&D Systems. Optical density
values were measured at a wavelength of 450 nm, using a
FLUOstar Optima plate reader (BMG Labtech). Concentra-
tions were calculated using a four-parameter fit curve.
siRNA transfection of BMDMs
Cells were plated at 1 ' 106 cells/ml in 12-well plates over-
night. On the day of transfection, the medium was replaced
with 500 #l of Dulbecco’s modified Eagle’s medium without
penicillin/streptomycin or FBS. Two Eppendorf microcentrifuges
were prepared for each siRNA to be transfected. Opti-MEM
(250#l/well) was added to each tube. RNAimax (add 5#l/well)
was added to one set of tubes, and siRNA (50 nM/well) was
added to the second set of tubes. The tubes containing the
siRNA were added to the tube with RNAimax, mixed well by
pipetting, and incubated for 15 min. The mix (500 #l) was
added to each well. 24 h post-transfection, cells were treated as
required.
Confocal microscopy and FRET analysis
BMDM cells were treated as required and washed in PBS
following treatments. The cells were fixed with 3.7% parafor-
maldehyde and stained with an antibody against TLR4 and
cholera toxin B subunit CF594 conjugate (Cambridge Biosci-
ences) before imaging on a Carl Zeiss, Inc. LSM510 META
confocal microscope (with an Axiovert 200 fluorescent micro-
scope) using a 1.4 numerical aperture ' 63 Zeiss objective. The
images were analyzed using LSM version 2.5 image analysis
software (Carl Zeiss, Inc.). To quantify the degree of co-local-
ization, we used the Costes approach. The Costes approach,
Pearson’s correlation coefficients, and p values were calculated
using MBF ImageJ with JACoP (Just Another Colocalisation
Plugin). Cells were also analyzed by FRET. As the rate of energy
transfer is inversely proportional to the sixth power of the
distance between donor and acceptor, the efficiency of energy
transfer (E) is defined with respect to r and R0, and the charac-
teristic Forster distance is described by the equation,E" 1/(1$
(r/R0)6). FRET was measured using a method described previ-
ously (23). Analysis was performed on 10 images from each
treatment with 4–5 cells/image.
Lipid raft extraction
RAW cells (1 ' 108) were treated with FASN inhibitor, C75
(50 #M), for 1 h. Cells were then treated with LPS (100 ng/ml)
for 15 min. Lipid rafts were isolated using the caveolae/raft
isolation kit (Sigma-Aldrich) according to the manufacturer’s
guidelines. After isolation, proteins were concentrated using
Strataclean resin (Stratagene), andTLR4presence or absence in
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raft fractions was analyzed by Western blotting in different
conditions.
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